SelK promotes glioblastoma cell proliferation by inhibiting β-TrCP1 mediated ubiquitin-dependent degradation of CDK4.
Li J, Zhao L, Wu Z, Huang S, Wang J, Chang Y, Liu L, Jin H, Lu J, Huang C, et al. J Exp Clin Cancer Res. 2024 Aug 19; 43(1):231. Epub 2024 Aug 19.